Immunodeficiency-Related Malignant Neoplasm

Immunodeficiency-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: AIDS Malignancy Consortium
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01961063	Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma	active not recruiting	Phase 1	3	City of Hope Medical CenterOTHER	1	Sep 1, 2026	clinicaltrials
NCT03220022	Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas	active not recruiting	Phase 1	46	National Cancer Institute (NCI)NIH	1	Aug 11, 2026